Equities
Health CareMedical Equipment and Services
  • Price (EUR)0.49
  • Today's Change-0.01 / -2.00%
  • Shares traded81.61k
  • 1 Year change-47.87%
  • Beta0.9319
Data delayed at least 15 minutes, as of Feb 13 2026 16:35 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Agfa Gevaert NV is a Belgium-based company that develops, produces and distributes analog and digital imaging systems and information technology (IT) solutions, mainly for the printing industry and the healthcare sector, as well as for specific industrial applications. The Company’s activities are divided into three independent business groups: Agfa Graphics, its dominant segment, which offers integrated pre-press solutions to the printing industry; Agfa HealthCare, which supplies hospitals and other healthcare centers with systems for capturing, processing and managing diagnostic images; and Agfa Specialty Products, which supplies a film-based products and high-tech solutions to business-to-business customers outside the graphic and healthcare markets. The Company is active worldwide through more than 40 wholly-owned sales organizations and runs manufacturing sites in Argentina, Brazil, China, France, Germany, Italy, Japan, South Korea, Taiwan the United Kingdom and the United States.

  • Revenue in EUR (TTM)1.11bn
  • Net income in EUR-71.00m
  • Incorporated1964
  • Employees4.74k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
EasyMotionSkin Tec GmbH-100.00bn-100.00bn58.40m17.00------------------------------------------------229.95---214.79------
Fonet Bilgi Teknolojileri AS11.89m3.18m61.39m504.0019.282.1110.615.160.17640.17640.65841.610.407420.986.791,203,616.0010.9116.4711.4818.2530.3031.6026.7936.961.53--0.01770.0033.2457.81-30.0259.2967.65--
OssDsign AB17.01m-4.81m63.72m32.00--2.18--3.75-0.5493-0.54932.062.800.51090.36726.955,629,938.00-14.46-25.42-16.05-28.5996.2985.57-28.30-82.426.33-13.770.0044--34.5148.59-2.68--24.28--
Optomed Oyj17.10m-6.64m63.93m111.00--2.66--3.74-0.3374-0.33740.86881.120.53632.875.07154,009.00-20.83-17.19-25.75-20.6963.6064.81-38.85-34.212.03-8.910.1014--13.675.61-21.83--5.30--
BioPorto A/S4.89m-11.62m64.42m48.00--12.56--13.16-0.1973-0.19730.0830.07740.41322.554.69962,131.60-98.08-65.22-133.92-88.7463.9064.15-237.40-222.221.71--0.1916--17.076.36-21.15---20.56--
Meditera Tibbi Mlzm Sny Tcrt AS48.07m-976.29k69.56m808.00--1.3038.241.45-0.4253-0.425320.9423.280.81082.844.853,257,490.00-1.876.25-2.237.4732.7042.44-2.316.902.17--0.01180.36-0.115155.2796.6241.97----
Senzime AB (publ)8.47m-11.39m74.16m50.00--2.25--8.75-0.8672-0.86720.63942.220.2341.735.991,794,120.00-31.47-35.09-34.04-37.5241.868.75-134.46-400.654.30-7.700.0399--63.5554.1811.50--40.12--
Agfa Gevaert NV1.11bn-71.00m75.86m4.74k--0.2643--0.0687-0.468-0.47966.771.850.82522.394.78233,073.20-5.15-4.74-7.10-6.8629.7729.67-6.24-6.361.172.500.3798---1.04-10.44-71.70--3.44--
Medicalgorithmics SA6.36m-3.65m75.99m117.00--4.86--11.94-1.55-1.552.696.620.2520.39136.83229,034.20-14.46-3.04-15.68-3.6287.2885.62-57.38-8.771.25-15.740.2309---44.31-32.70-2,682.18---48.46--
Omda AS42.13m-2.69m76.95m260.00--25.4829.271.83-1.51-1.5123.591.630.679326.5921.701,772,075.00-4.33-5.14-5.39-6.6393.6991.09-6.37-10.320.64830.52810.9359--3.4515.80-163.95---15.57--
Creo Medical Group PLC2.53m14.49m79.46m133.005.661.134.9731.400.02960.02720.00560.14770.0319-0.80340.330816,541.3518.25-29.2520.62-35.8945.4547.22572.73-176.824.75-69.500.0645--0.00212.28-17.30---18.58--
Nexstim Oyj10.06m-282.99k84.40m40.00--26.43127.158.39-0.042-0.0421.470.44260.85530.56134.66251,616.80-2.40-12.40-4.17-20.7694.3695.09-2.81-16.291.080.78350.6002--20.5521.1432.79--15.13--
C Rad AB41.74m982.08k86.22m110.0089.412.7044.112.070.31040.310413.2510.280.89284.292.404,018,182.002.107.012.999.8151.9546.992.357.122.771.550.02642.44-5.7814.80-81.40-6.08----
Medinice SA4.51k8.87m88.21m11.007.883.979.8819,550.825.085.080.002610.080.0003--0.03771,727.2763.4010.9565.1911.32-1,200.0049.36196,605.301,642.72----0.0024---16.442.77840.87--26.08--
Inspecs Group PLC221.77m-3.81m88.28m1.65k--0.86158.220.3981-0.0326-0.08061.900.87640.91382.317.71116,586.50-1.57-2.16-2.31-3.1351.8649.60-1.72-2.790.88471.730.3969---2.4832.80-362.19--4.97--
Mercator Medical SA139.00m21.81m89.47m950.004.110.42193.160.64379.899.8963.0596.360.58752.926.30616,168.409.2422.7810.0925.8716.1636.7515.7223.784.54--0.02582.0015.650.0796359.45--3.76--
Data as of Feb 13 2026. Currency figures normalised to AGFA Gevaert NV's reporting currency: Euro EUR

Institutional shareholders

27.84%Per cent of shares held by top holders
HolderShares% Held
Shareholder Value Management AGas of 31 Jul 20258.02m5.18%
Axxion SA (Luxembourg)as of 18 Apr 20257.94m5.13%
LLB Fund Services AGas of 18 Apr 20257.06m4.56%
BWM AGas of 31 Dec 20255.25m3.39%
Boldhaven Management LLPas of 18 Apr 20254.88m3.15%
Norges Bank Investment Managementas of 18 Apr 20254.64m3.00%
Aguja Capital GmbHas of 31 Oct 20252.10m1.36%
Dimensional Fund Advisors LPas of 05 Feb 20261.36m0.88%
Deka Investment GmbHas of 30 Sep 2025997.21k0.64%
KBC Asset Management NVas of 30 Jun 2025846.98k0.55%
More ▼
Data from 18 Apr 2025 - 31 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.